BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33261029)

  • 1. Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Outcomes in Patients with Extranodal Natural Killer/T-Cell Lymphoma.
    Ryu KJ; Lee JY; Choi ME; Yoon SE; Cho J; Ko YH; Shim JH; Kim WS; Park C; Kim SJ
    Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33261029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of exosomal miRNAs between breast cancer patients with and without recurrence.
    Sueta A; Yamamoto Y; Tomiguchi M; Takeshita T; Yamamoto-Ibusuki M; Iwase H
    Oncotarget; 2017 Sep; 8(41):69934-69944. PubMed ID: 29050253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating exosomal microRNAs as diagnostic and prognostic biomarkers in patients with diffuse large B-cell lymphoma.
    Cao D; Cao X; Jiang Y; Xu J; Zheng Y; Kang D; Xu C
    Hematol Oncol; 2022 Apr; 40(2):172-180. PubMed ID: 34874565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor.
    Warnecke-Eberz U; Chon SH; Hölscher AH; Drebber U; Bollschweiler E
    Tumour Biol; 2015 Jun; 36(6):4643-53. PubMed ID: 25631748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Throughput Sequencing-Based Identification of Serum Exosomal Differential miRNAs in High-Grade Glioma and Intracranial Lymphoma.
    Wang S; Xu Z; Zhang C; Yu R; Jiang J; Wang C; Qu C
    Biomed Res Int; 2020; 2020():2102645. PubMed ID: 33083454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
    Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
    BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancer.
    Kim DH; Park H; Choi YJ; Im K; Lee CW; Kim DS; Pack CG; Kim HY; Choi CM; Lee JC; Ji W; Rho JK
    Biomark Res; 2023 Sep; 11(1):80. PubMed ID: 37705067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Exosomal miRNA-1226 as Potential Biomarker of Pancreatic Ductal Adenocarcinoma.
    Wang C; Wang J; Cui W; Liu Y; Zhou H; Wang Y; Chen X; Chen X; Wang Z
    Onco Targets Ther; 2021; 14():1441-1451. PubMed ID: 33664577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
    Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
    BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal MicroRNA Analyses in Esophageal Squamous Cell Carcinoma Cell Lines.
    Kim S; Kim GH; Park SJ; Kwon CH; I H; Lee MW; Lee BE
    J Clin Med; 2022 Jul; 11(15):. PubMed ID: 35956043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
    Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
    Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q; Yu Z; Yuan S; Xie W; Li C; Hu Z; Xiang Y; Wu N; Wu L; Bai L; Li Y
    Oncotarget; 2017 Feb; 8(8):13048-13058. PubMed ID: 28055956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A panel of serum exosomal microRNAs as predictive markers for chemoresistance in advanced colorectal cancer.
    Jin G; Liu Y; Zhang J; Bian Z; Yao S; Fei B; Zhou L; Yin Y; Huang Z
    Cancer Chemother Pharmacol; 2019 Aug; 84(2):315-325. PubMed ID: 31089750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of Four Serum Exosomal MiRNAs as Novel Diagnostic Biomarkers for Early-Stage Gastric Cancer.
    Tang S; Cheng J; Yao Y; Lou C; Wang L; Huang X; Zhang Y
    Front Genet; 2020; 11():237. PubMed ID: 32256526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
    Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
    Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal miRNA profiling before and after surgery revealed potential diagnostic and prognostic markers for lung adenocarcinoma.
    Xue X; Wang C; Xue Z; Wen J; Han J; Ma X; Zang X; Deng H; Guo R; Asuquo IP; Qin C; Wang H; Gao Q; Liu S; Wang J
    Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):281-293. PubMed ID: 32073597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models.
    Yu LX; Zhang BL; Yang Y; Wang MC; Lei GL; Gao Y; Liu H; Xiao CH; Xu JJ; Qin H; Xu XY; Chen ZS; Zhang DD; Li FG; Zhang SG; Liu R
    Oncol Rep; 2019 Jan; 41(1):257-269. PubMed ID: 30542726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
    Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
    Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Role of Circulating Exosomal miR-425-3p for the Response of NSCLC to Platinum-Based Chemotherapy.
    Yuwen D; Ma Y; Wang D; Gao J; Li X; Xue W; Fan M; Xu Q; Shen Y; Shu Y
    Cancer Epidemiol Biomarkers Prev; 2019 Jan; 28(1):163-173. PubMed ID: 30228154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma.
    Kim SJ; Ryu KJ; Park B; Yoon SE; Cho J; Park Y; Kim WS
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.